Appropriate intraprocedural initial heparin dosing in patients undergoing catheter ablation for atrial fibrillation receiving uninterrupted non-vitamin-K antagonist oral anticoagulant treatment

Appropriate intraprocedural initial heparin dosing in patients undergoing catheter ablation for atrial fibrillation receiving uninterrupted non-vitamin-K antagonist oral anticoagulant treatment

Abstract Background To clarify the appropriate initial dosage of heparin during radiofrequency catheter ablation (RFCA) in patients with atrial fibrillation (AF) receiving uninterrupted nonvitamin K antagonist oral anticoagulant (NOAC) treatment. Methods A total of 187 consecutive AF patients who un...

Full description

Bibliographic Details
Main Authors: Rong-feng Zhang, Cheng-ming Ma, Na Wang, Ming-hui Yang, Wen-wen Li, Xiao-meng Yin, Ying-xue Dong, Xiao-hong Yu, Xian-jie Xiao, Yun-long Xia, Lian-jun Gao
Format: Article
Language:English
Published: BMC 2021-04-01
Series:BMC Cardiovascular Disorders
Subjects:
Atrial fibrillation
New oral anticoagulants
Radiofrequency catheter ablation
Bleeding
Online Access:https://doi.org/10.1186/s12872-021-02032-3

Internet

https://doi.org/10.1186/s12872-021-02032-3

Similar Items